SIGNIFICANCE OF PULSE PRESSURE AND MANAGEMENT STRATEGY OF THE PETIENTS WITH PERMANENT CARDIAC PACING
Анотація
Clinical importance of the pulse pressure (PP) in patients with permanent pacemaker (PM) is discussed in this review. Clinical characteristics, hemodynamic parameters, stimulation parameters, depending on the PP, and the ability to optimize medication with antihypertensive drugs are considered. Implanted pacemaker and CRT are changing the PP, which substantiates the need for additional medical supervision. PP is an independent predisposing and prognostic factor for cardiovascular complications and mortality, and therefore is being intensively studied. The implantation of pacemaker and CRT, solves the problem of bradysystolic arrhythmias and HF, and leads to regular changes in PP among the other hemodynamic parameters. The PP role and abilities of its optimization, including due to medical management of patients, is still not studied appropriately.
Завантаження
Посилання
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association / [M. Brignole, A. Auricchio, G. Baron-Esquivias et al.]. // Eur Heart J. – 2013. – № 34. – p. 2281–329.
Rapsang A. Pacemakers and implantable cardioverter defibrillators--general and anesthetic considerations / A. Rapsang, P. Bhattacharyya. // Braz J Anesthesiol. – 2014. – № 64. – p. 205–14.
TUGENDHAT: a pilot randomized study on effects of biventricular pacing in patients with bradycardia pacing indication and normal systolic function on heart failure, atrial fibrillation and quality of life (results of 12 month follow-up) / [M. Taborsky, D. Rihova, T. Mraz et al.]. // Bratisl Lek Listy. – 2013. – № 114. – p. 323–9.
Reverse ventricular remodeling and long-term survival in patients undergoing cardiac resynchronization with surgically versus percutaneously placed left ventricular pacing leads / [J. Rickard, D.R. Johnston, J. Price et al.]. // Heart Rhythm. – 2015. – № 12. – p. 517–23.
Trends in permanent pacemaker implantation in the United States from 1993 to 2009: increasing complexity of patients and procedures / [A. Greenspon, J. Patel, E. Lau et al.]. // J Am Coll Cardiol. – 2012. – № 60. – p. 1540–5.
2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing / [B. F. Wilkoff, L. Fauchier, M. K. Stiles et al.]. // Arrhythmia. – 2016. – № 32. – p. 1–28.
Kumar P. Device Therapies: New Indications and Future Directions / P. Kumar, J. D. Schwartz. // Current Cardiology Reviews. – 2015. – № 11. – p. 33–41.
Yu C. M. Cardiac resynchronization therapy: state of the art 2013 / C. M. Yu, D. L. Hayes. // European Heart Journal. – 2013. – № 34. – p. 1396–403.
Brabham W.W. The role of AV and VV optimization for CRT / W. W. Brabham, M. R. Gold // Journal of Arrhythmia. – 2013. – № 29. – p. 153–161.
Lewis G. F. Developments in Cardiac Resynchronisation Therapy / G. F. Lewis, M. R. Gold // Arrhythmia & Electrophysiology Review. - 2015. - № 4. – p. 122-28.
Central pulse pressure but not brachial blood pressure is the predominant factor affecting aortic arterial stiffness / [W. K. Xiao, P. Ye, Y. Y. BaiY et al.]. // Nan Fang Yi Ke Da Xue Xue Bao. – 2015. – № 35. – p. 34–9.
Pulse pressure amplification in relation to body fatness / [A. Wykretowicz, A. Rutkowska, T. Krauze et al.]. // British Journal of Clinical Pharmacology. – 2012. – № 73. – p. 546–552.
Beat-to-beat, ambulatory hour-to-hour, and home day-to-day variabilities in blood pressure, pulse pressure, and heart rate in comparison with each other and with target-organ damage / J. K. Johansson, P. J. Puukka, R. Virtanen, A. M. Jula. // Blood Press Monit. – 2015. – №20. – p. 113–20.
Outcome-driven thresholds for ambulatory pulse pressure in 9938 participants recruited from 11 populations / [Y. M. Gu, L. Thijs, Y. Li et al.]. // Hypertension. – 2014. – № 63. – p. 229–37.
2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension / [G. Mancia, R. Fagard, K. Narkiewicz et al.]. // Journal of Hypertension. – 2013. – № 31. – p. 1925–38.
Clinical Practice Guidelines for the Management of Hypertension in the Community A Statement by the American Society of Hypertension and the International Society of Hypertension / [M. A. Weber, E. L. Schiffrin, W. B. White et al.]. // J Clin Hypertens (Greenwich). – 2014. – № 16. – p. 14–26.
Zhestkost' sosudistoy stenki u patsiyentov s arterial'noy gipertoniyey / [O. D. Ostroumova, A. I. Kochetkov, I. I. Kopchenov et al.]. // Sistemnyye gipertenzii. – 2015. – № 2. – s. 43–48.
Drapkina O. M. Zhestkost' sosuPokazateli zhestkosti sosudistoy stenki i dlinna telomera pri arterial'noy gipertoniidistoy stenki u patsiyentov s arterial'noy gipertoniyey / O. M. Drapkina, R. N. Shepel', V. T. Ivashkin. // Klinicheskaya meditsina Kazakhstana. – 2015. – № 2. – s. 6–10.
Visit-to-visit variability in systolic blood pressure: correlated with the changes of arterial stiffness and myocardial perfusion in on-treated hypertensive patients / [H. Song, F. Wei, Z. Liu et al.]. // Clin Exp Hypertens. – 2015. – № 37. – p. 63–69.
Doppler indexes of left ventricular systolic and diastolic flow and central pulse pressure in relation to renal resistive index / [T. Kuznetsova, N. Cauwenberghs, J. Knez et al.]. // Am J Hypertens. – 2015. – № 28. – p. 535–45.
Lyzohub V. H. Age-related features of neurohumoral effects of dopamine activity on the cardiovascular system in elderly people / V. H. Lyzohub, O. V. Dolynna, T. V. Zaval's'ka. // Lik Sprava. – 2012. – № 8. – p. 13–21.
International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes Investigators. Significance of white-coat hypertension in older persons with isolated systolic hypertension: a meta-analysis using the International Database on Amb / [S. S. Franklin, L. Thijs, T. W. Hansen et al.]. // Hypertension. – 2012. – № 59. – p. 564–71.
Relative effectiveness of clinic and home blood pressure monitoring compared with ambulatory blood pressure monitoring in diagnosis of hypertension: systematic review [Electronic resource] / [J. Hodgkinson, J. Mant, U. Martin et al.] // BMJ. – 2011. – Access to resource: http://dx.doi.org/10.1136/bmj.d3621.
Effects of olmesartan on arterial stiffness in rats with chronic renal failure / Y. C.Chuang, M. S. Wu, Y. K. Su, K. M. Fang. // Cardiovasc. Diabetol. – 2012. – № 13. – p. 11–66.
A reverse dipping pattern predicts cardiovascular mortality in a clinical cohort / [B. K. Kim, Y. M. Kim, Y. Lee et al.]. // J Korean Med Sci. – 2013. – № 28. – p. 1468–73.
Elevated Pulse Pressure is Associated with Hemolysis, Proteinuria and Chronic Kidney Disease in Sickle Cell Disease [Electronic resource] / [E. M. Novelli, M. Hildesheim, C. Rosano et al.] // PLoS ONE. – 2014. – Access to resource: http://doi.org/10.1371/journal.pone.0114309.
Bidani A. K. Hypertension and Chronic Kidney Disease Progression: Why the Suboptimal Outcomes? / A. K. Bidani, K. A. Griffin, M. Epstein. // American journal of medicine. – 2012. – № 125. – p. 1057–62.
Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011–2012 / T. Nwankwo, S. S. Yoon, V. Burt, Q. Gu. // NCHS Data Brief. – 2013. – № 133. – p. 1–8.
Association between Usual Sodium and Potassium Intake and Blood Pressure and Hypertension among U.S. Adults: NHANES 2005–2010 [Electronic resource] / [Z. Zhang, M. E. Cogswell, C. Gillespie et al.] // PLoS ONE. – 2013. – Access to resource: http://doi.org/10.1371/journal.pone.0075289.
Heart Disease and Stroke Statistics—2012 Update: A Report From the American Heart Association [Electronic resource] / [V. L. Roger, A. S. Go, D. M. Lloyd-Jones et al.] // Circulation. – 2012. – Access to resource: http://doi.org/10.1161/CIR.0b013e31823ac046.
Usual blood pressure, peripheral arterial disease, and vascular risk: cohort study of 4.2 million adults [Electronic resource] / [C. A. Emdin, S. G. Anderson, T. Callender et al.] // BMJ. – 2015. – Access to resource: http://doi.org/10.1136/bmj.h4865.
Arterial stiffness and pulse-pressure amplification in overweight/obese African-American adolescents: relation with higher systolic and pulse pressure [Electronic resource] / [G. L. Pierce, H. Zhu, K. Darracott et al.] // Am J Hypertens. – 2013. – Access to resource: http://doi.org/10.1093/ajh/hps014.
Aortic and Carotid Arterial Stiffness and Epigenetic Regulator Gene Expression Changes Precede Blood Pressure Rise in Stroke-Prone Dahl Salt-Sensitive Hypertensive Rats [Electronic resource] / [V. L. Herrera, J. L. Decano, N. Giordano et al.] // PLoS ONE. – 2014. – Access to resource: http://doi.org/10.1371/journal.pone.0107888.
Hemodynamic effect of atrioventricular and interventricular dyssynchrony in patients with biventricular pacing: Implications for the pacemaker syndrome / [R. Mollazadeh, L. Mohimi, M. Zeighami et al.]. // J Cardiovasc Dis Res. – 2012. – № 3. – p. 200–203.
Davidovich I. M. Vliyaniye razlichnykh rezhimov postoyannoy elektrokardiostimulyatsii na sutochnyy profil' arterial'nogo davleniya u lits s ishemicheskoy bolezn'yu serdtsa v sochetanii s gipertonicheskoy bolezn'yu / I. M. Davidovich, T. E. Neapolitanskaya. // Dal'nevostochnyy meditsinskiy zhurnal. – 2012. – № 2. – s. 14–18.
Comparison of low versus high (>40 mm Hg) pulse pressure to predict the benefit of cardiac resynchronization therapy for heart failure (from the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy Trial) / [S. Sherazi, I. Goldenberg, A. J. Moss et al.]. // Am J Cardiol. – 2014. – № 114. – p. 1053–8.
First-degree atrioventricular block is associated with heart failure and death in persons with stable coronary artery disease: data from the Heart and Soul Study / [R. K. Crisel, R. Farzaneh-Far, B. Na et al.]. // European Heart Journal. – 2011. – № 32. – p. 1875–78.
Heidenriech P. A. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association / P. A. Heidenriech, J. G. Trogdon, O. A. Khavjou. // Circulation. – 2011. – № 123. – p. 933–44.
Laurent G. First-degree atrioventricular block and pseudopacemaker syndrome / G. Laurent, J. C. Eicher, J. E. Wolf. // Arch Cardiovasc Dis. – 2013. – № 106. – p. 690–3.
Holmqvist F. First-degree AV block-an entirely benign finding or a potentially curable cause of cardiac disease? / F. Holmqvist, J. P. Daubert. // Ann Noninvasive Electrocardiol. – 2013. – № 18. – p. 215–24.
Marked First Degree Atrioventricular Block: an extremely prolonged PR interval associated with AtrioventricularDissociation in a young Nigerian man with Pseudo-Pacemaker Syndrome: a case report / O.Ogunlade, A. O. Akintomide, O. E. Ajayi, O. A. Eluwole. // BMC Res Notes. – 2014. – № 7. – p. 781.
Association of blood pressure and aortic distensibility with P wave indices and PR interval: the Multi-Ethnic Study of Atherosclerosis (MESA) [Electronic resource] / [A. Alonso, E. Z. Soliman, L. Y. Chen et al.] // J Electrocardiol. – 2013. – Access to resource: http://doi.org/10.1016/j.jelectrocard.2013.01.009.
Holmqvist F. Adverse effects of first-degree AV-block in patients with sinus node dysfunction: data from the mode selection trial / F. Holmqvist, A. S. Hellkamp, K. L. Lee. // Pacing Clin Electrophysiol. – 2014. – № 37. – p. 1111–9.
De Maria E. Disappearance of orthostatic hypotension after pacemaker implantation in a patient with a long PR interval / E. De Maria, P. L. Fontana, S. Cappelli. // Indian Heart Journal. – 2013. – № 65. – p. 95–99.
Association of longer QT interval with arterial waveform and lower pulse pressure amplification: the Nagahama Study / [Y. Tabara, Y. Takahashi, K. Kohara et al.]. // Am J Hypertens. – 2013. – № 26. – p. 973–80.
Comparison of DDD versus VVIR pacing modes in elderly patients with atrioventricular block / [B. Kılıçaslan, A. F. Vatansever, E. E. Kılıçaslan et al.]. // Turk Kardiyol Dern Ars. – 2012. – № 40. – p. 331–6.
Biventricular pacing for atrioventricular block and systolic dysfunction / [A. B. Curtis, S. J. Worley, P. B. Adamson et al.]. // N Engl J Med. – 2013. – № 368. – p. 1585–93.
Funktsionalʹnyy klas sertsevoyi nedostatnosti ta osnovni sertsevo-sudynni stany u patsiyentiv iz implantovanymy elektrokardiostymulyatoramy na richnomu etapi aparatnoyi i medykamentoznoyi / I. M. Kolomytseva, D. YE. Volkov, D. A. Lopyn, M. I. Yabluchansʹky. // Aktualʹni problemy suchasnoyi medytsyny: visnyk Ukrayinsʹkoyi medychnoyi stomatolohichnoyi akademiyi. – 2015. – № 3. – s. 136–40.
Feng J. L. Long-term effect of different right ventricular apex pacing ratio on heart structure and function of patients with dual chamber pacemaker / J. L. Feng, Y. Zhang, Z. P. Li. // Beijing Da Xue Xue Bao. – 2014. – № 46. – p. 879–82.
Manhyleva T. A. Osobennosty sutochnoy dynamyky arteryalʹnoho davlenyya u bolʹnykh s arteryalʹnoy hypertenzyey pry postoyannoy y peremennoy chastote sokrashchenyy zheludochkov serdtsa / T. A. Manhyleva. // Sertse i sudyny. – 2011. – № 2. – s. 76–82.
Prevention of syncope through permanent cardiac pacing in patients with bifascicular block and syncope of unexplained origin: the PRESS study / [M. Santini, A. Castro, F. Giada et al.]. // Circ Arrhythm Electrophysiol. – 2013. – № 6. – p. 101–7.
Hurtado-Hernández Z. Acute neurological deficit, pleural chest pain and trifascicular block: presentation of a case of atypical infectious endocarditis / Z. Hurtado-Hernández, A. Segura-Domínguez. // Semergen. – 2014. – № 40. – p. 47–9.
Bussink B. E. Right bundle branch block: prevalence, risk factors, and outcome in the general population: results from the Copenhagen City Heart Study / B. E. Bussink, A. G. Holst, L. Jespersen. // European Heart Journal. – 2013. – № 34. – p. 138–46.
Lotina A. S. Prognostic value of left bundle brunch block in patients with acute coronary syndrome / A. S. Lotina, D. V. Dupliakov, A. D. Érlikh. // Kardiologiia. – 2013. – № 53. – p. 35–9.
Prevalence and long-term prognosis of patients with complete bundle branch block (right or left bundle branch) with normal left ventricular ejection fraction referred for stress echocardiography / [A. A. Supariwala, J. R. Po, S. Mohareb et al.]. // Echocardiography. – 2015. – № 32. – p. 483–9.
Relation of New Permanent Right or Left Bundle Branch Block on Short- and Long-Term Mortality in Acute Myocardial Infarction Bundle Branch Block and Myocardial Infarction / [A. Melgarejo-Moreno, J. Galcerá-Tomás, L. Consuegra-Sánchez et al.]. // Am J Cardiol. – 2015. – № 116. – p. 1003–9.
Prognostic values of bundle branch blocks for cardiovascular mortality in Japanese (24year follow-up of NIPPON DATA80) / [Y. Nakamura, T. Okamura, T. Inohara et al.]. // J Electrocardiol. – 2013. – № 46. – p. 360–5.
Impact of left bundle branch block on heart rate and its relationship to treatment with ivabradine in chronic heart failure / [J. C. Reil, M. Robertson, I. Ford et al.]. // Eur J Heart Fail. – 2013. – № 15. – p. 1044–52.
Empiric pacemaker compared with a monitoring strategy in patients with syncope and bifascicular conduction block--rationale and design of the Syncope: Pacing or Recording in ThE Later Years (SPRITELY) study / [A. D. Krahn, C. A. Morillo, T. Kus et al.]. // Europace. – 2012. – № 14. – p. 1044–8.
Vyskubova Ye. V. Kompensatornyye mekhanizmy podderzhaniya kontraktil'noy funktsii levogo zheludochka u bol'nykh s polnoy blokadoy levoy nozhki puchka Gisa / Ye. V. Vyskubova, V. M. Pokrovskiy. // Kubanskiy nauchnyy meditsinskiy vestnik. – 2012. – № 2. – s. 44–6.
Low diastolic blood pressure was one of the independent predictors of ischemia-like findings of electrocardiogram in patients who underwent coronary angiography / [S. Fujishima, N. Murakami, J. Haga et al.]. // J. Cardiol. – 2012. – № 62. – p. 230–5.
Inverse Relationship of Blood Pressure to Long-Term Outcomes and Benefit of Cardiac Resynchronization Therapy in Patients With Mild Heart Failure: A Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Long-Term Fo / [Y. Biton, A. J. Moss, V. Kutyifa et al.]. // Circ Heart Fail. – 2015. – № 8. – p. 921–6.
Choudhury M. Choudhury M. Biology of the Sinus Node and its Disease / M. Choudhury, M. R. Boyett, G. M. Morris. // Arrhythmia & Electrophysiology Review. – 2015. – № 4. – p. 28–34.
Incidence of and risk factors for sick sinus syndrome in the general population / [P. N. Jensen, N. N. Gronroos, L. Y. Chen et al.]. // J Am Coll Cardiol. – 2014. – № 64. – p. 531–8.
Ewy G. A. Sick sinus syndrome: synopsis / G. A. Ewy. // J Am Coll Cardiol. – 2014. – № 64. – p. 539–40.
Right versus left atrial pacing in patients with sick sinus syndrome and paroxysmal atrial fibrillation (Riverleft study): study protocol for randomized controlled trial [Electronic resource] / [T. T. Ramdjan, L. J. van der Does, P. Knops et al.] // Trials. – 2014. – Access to resource: http://doi.org/10.1186/1745-6215-15-445.
A comparison of single-lead atrial pacing with dual-chamber pacing in sick sinus syndrome / [J. C. Nielsen, P. E. Thomsen, S. Hojberg et al.]. // European Heart Journal. – 2011. – № 32. – p. 686–96.
Association of sick sinus syndrome with incident cardiovascular disease and mortality: the Atherosclerosis Risk in Communities study and Cardiovascular Health Study [Electronic resource] / [A. Alonso, P. N. Jensen, F. L. Lopez et al.] // PLoS One. – 2014. – Access to resource: http://doi.org/10.1371/journal.pone.0109662.
Health economic evaluation of single-lead atrial pacing vs. dual-chamber pacing in sick sinus syndrome / [L. Oddershede, S. Riahi, J. C. Nielsen et al.]. // Europace. – 2014. – № 16. – p. 866–72.
AAIR or DDDR pacing for sick sinus syndrome: the physiologic conundrum / L.Padeletti, G. Pontecorboli, A. Michelucci, H. G. Mond. // Europace. – 2012. – № 14. – p. 781–2.
HRS/ACCF expert consensus statement on pacemaker device and mode selection. Developed in partnership between the Heart Rhythm Society (HRS) and the American College of Cardiology Foundation (ACCF) and in collaboration with the Society of Thoracic Surgeons / [A. M. Gillis, A. M. Russo, K. A. Ellenbogen et al.]. // Heart Rhythm. – 2012. – № 9. – p. 1344–65.
Kolpakov P. Ye. Uchashchayushchaya elektrokardiostimulyatsiya serdtsa u kardiokhirurgicheskikh bol'nykh / P. Ye. Kolpakov, A. A. Yeremenko. // Vestnik aritmologii. – 2003. – № 31. – s. 5–9.
Gauer R. L. Evaluation of syncope / R. L. Gauer. // Am Fam Physician. – 2011. – № 84. – p. 640–50.
Syncope recurrence and mortality: a systematic review / [M. Solbiati, G. Casazza, F. Dipaola et al.]. // Europace. – 2015. – № 17. – p. 300–8.
At the heart of the arterial baroreflex: a physiological basis for a new classification of carotid sinus hypersensitivity / [W. Wieling, C. T. Krediet, D. Solari et al.]. // J Intern Med. – 2013. – № 273. – p. 345–58.
Head turning-induced hypotension in elderly people [Electronic resource] / [Y. Schoon, M. G. Olde Rikkert, S. Rongen et al.] // PLoS One. – 2013. – Access to resource: http://doi.org/10.1371/journal.pone.0072837.
Seifer C. Carotid sinus syndrome / C. Seifer. // Cardiol Clin. – 2013. – № 31. – p. 111–21.
Syncope : epidemiology, definition, classification, pathophysiology and prognosis / [C. H. Heeger, A. Rillig, F. Ouyang et al.]. // Herz. – 2014. – № 39. – p. 423–8.
Krediet C. T. Dissection of carotid sinus hypersensitivity: the timing of vagal and vasodepressor effects and the effect of body position / C. T. Krediet, D. L. Jardine, W. Wieling. // Clin Sci (Lond). – 2011. – № 121. – p. 389–96.
The role of pacemaker in hypersensitive carotid sinus syndrome / [R. Lopes, A. Gonçalves, J. Campos et al.]. // Europace. – 2011. – № 13. – p. 572–5.
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC) / [P. M. Elliott, A. Anastasakis, M. A. Borger et al.]. // Eur Heart J. – 2014. – № 35. – p. 2733–79.
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientif / [B. J. Maron, J. E. Udelson, R. O. Bonow et al.]. // J Am Coll Cardiol. – 2015. – № 66. – p. 2362–71.
New perspectives on the prevalence of hypertrophic cardiomyopathy / C. Semsarian, J. Ingles, M. S. Maron, B. J. Maron. // J Am Coll Cardiol. – 2015. – № 65. – p. 1249–54.
A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients wi [Electronic resource] / [C. O'Mahony, M. Tome-Esteban, P. D. Lambiase et al.] // Heart. – 2013. – Access to resource: http://doi.org/10.1136/heartjnl-2012-303271.
Apical hypertrophic cardiomyopathy associated with chronic hypertension: diagnostic and management implications / C.Macatangay, R. Marfatia, E. Kaloudis, E. Avelar. // Conn Med. – 2012. – № 76. – p. 147–50.
Low exercise blood pressure and risk of cardiovascular events and all-cause mortality: systematic review and meta-analysis / P. A. Barlow, M. G. Schultz, C. M. Shing, J. E. Sharman. // Atherosclerosis. – 2014. – № 237. – p. 13–22.
Initial experience of a cohort of patients with hypertrophic cardiomyopathy undergoing biventricular pacing / [C. A. Rinaldi, S. Kirubakaran, C. A. Bucknall et al.]. // Indian Pacing Electrophysiol J. – 2011. – № 11. – p. 5–14.
Maron B. J. Historical perspectives on the implantable cardioverter-defibrillator and prevention of sudden death in hypertrophic cardiomyopathy / B. J. Maron. // Card Electrophysiol Clin. – 2015. – № 7. – p. 165–71.
Very late effects of dual chamber pacing therapy for obstructive hypertrophic cardiomyopathy / [A. Lucon, L. Palud, D. Pavin et al.]. // Arch Cardiovasc Dis. – 2013. – № 106. – p. 373–81.
Effect of cardiac resynchronization on gradient reduction in patients with obstructive hypertrophic cardiomyopathy: preliminary study / [R. Lenarczyk, A. Woźniak, O. Kowalski et al.]. // Pacing Clin Electrophysiol. – 2011. – № 34. – p. 1544–52.
Outcome and complications after implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: systematic review and meta-analysis / [A. F. Schinkel, P. A. Vriesendorp, E. J. Sijbrands et al.]. // Circ Heart Fail. – 2012. – № 5. – p. 552–9.
Hradec J. Chronic heart failure / J. Hradec. // Cas Lek Cesk. – 2015. – №154. – p. 260–8.
Berezin A. Ye. Sistolicheskaya i diastolicheskaya serdechnaya nedostatochnost': dve storony odnogo protsessa? Obzor literatury / A. Ye. Berezin. // Ukraí̈ns'kiy medichniy chasopis. – 2014. – № 3. – s. 91–96.
Gupta A. Guidelines in review: 2013 ACCF/AHA Guideline for the Management of Heart Failure [Electronic resource] / A. Gupta, G. Ghimire, F. G. Hage // J Nucl Cardiol. – 2014. – Access to resource: http://doi.org/10.1007/s12350-013-9832-x.
Alsamara M. Heart failure with preserved ejection fraction. Expert Rev / M. Alsamara, R. Alharethi. // Cardiovasc. Ther. – 2014. – № 12. – p. 743–50.
Differing prognostic value of pulse pressure in patients with heart failure with reduced or preserved ejection fraction: results from the MAGGIC individual patient meta-analysis / [C. E. Jackson, D. Castagno, A. P. Maggioni et al.]. // Eur Heart J. – 2015. – № 36. – p. 1106–14.
A low pulse pressure predicts mortality in subjects with heart failure after an acute myocardial infarction: a post-hoc analysis of the CAPRICORN study / [C. J. Petrie, A. A. Voors, M. Robertson et al.]. // Clin Res Cardiol. – 2012. – № 101. – p. 29–35.
Cardiac-resynchronization therapy in patients with systolic heart failure and QRS interval ≤ 130 ms: insights from a meta-analysis / [R. M. Shah, D. Patel, J. Molnar et al.]. // Europace. – 2015. – № 17. – p. 267–73.
Extrasystolic stimulation with bi-ventricular pacing: an acute haemodynamic evaluation / [B. Stegemann, A. Mihalcz, C. Földesi et al.]. // Europace. – 2011. – № 13. – p. 1591–6.
Zhang Q. Incidence, definition, diagnosis, and management of the cardiac resynchronization therapy nonresponder / Q. Zhang, Y. Zhou, C. M. Yu. // Curr Opin Cardiol. – 2015. – № 30. – p. 40–9.
Practical questions around individual with a pacemaker or an implantable cardioverter defibrillator / [C. Manaouil, S. Fantoni, D. Montpellier et al.]. // Presse Med. – 2012. – № 41. – p. 736–44.
Patients with pacemaker or implantable cardioverter-defibrillator / P. M.Schulman, M. A. Rozner, V. Sera, E. C. Stecker. // Med Clin North Am. – 2013. – № 97. – p. 1051–75.
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis / [D. Ettehad, C. A. Emdin, A. Kiran et al.]. // Lancet. – 2016. – № 387. – p. 957–67.
Antiplatelet agents increase hemorrhagic risk in patients undergoing a cardiac pacemaker or ICD implantation / W.Amara, I. Ben Youssef, F. Monsel, J. Sergent. // Ann Cardiol Angeiol (Paris). – 2011. – № 60. – p. 267–71.
Shanina I. V. Experience of management of the patient with the resynchronization biventricular pacing without destruction of atrio-ventricular node suffering from chronic heart failure and permanent atrial fibrillation / I. V. Shanina, D. E. Volkov, D. A. Lopin. // Journal of V. N. Karazin` KhNU. – 2013. – № 25. – p. 72–76.
Diagnosis and choice of the management strategy in patients with cardiac resynchronization therapy in case of chronic heart failure with multimorbidit / [D. G. Drokin, I. V. Shanina, D. E. Volkov et al.]. // Journal of V. N. Karazin` KhNU. – 2013. – № 26. – p. 61–65.
Kisliak O. A. Pulse wave velocity and pulse pressure in patients with arterial hypertension / O. A. Kisliak, A. V. Starodubova. // Kardiologiia. – 2014. – № 54. – p. 34–8.
The effect of spironolactone in patients with resistant arterial hypertension in relation to baseline blood pressure and secondary causes of hypertension / [J. Vaclavik, R. Sedlak, J. Jarkovsky et al.]. // Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. – 2013. – № 157. – p. 50–5.
Widimský J. PATHWAY-2 Study: spironolactone vs placebo, bisoprolol and doxazosin to determine optimal treatment of resistant hypertension. Spironolactone high effective in lowering blood pressure in drug resistant hypertension / J. Widimský. // Vnitr Lek. – 2015. – № 61. – p. 1067–71.
Blood pressure-lowering efficacy of loop diuretics for primary hypertension [Electronic resource] / [V. M. Musini, P. Rezapour, J. M. Wright et al.] // Cochrane Database Syst Rev. – 2015. – Access to resource: http://doi.org/10.1002/14651858.CD003825.pub4.
Development and Validation of Predictive Models of Cardiac Mortality and Transplantation in Resynchronization Therapy / [E. A. Rocha, F. T. Pereira, J. S. Abreu et al.]. // Arq Bras Cardiol. – 2015. – № 105. – p. 399–409.
Techeniye khronicheskoy serdechnoy nedostatochnosti i medikamentoznaya terapiya patsiyentov s implantiruyemymi elektrokardiostimulyatorami / I. N.Kolomytseva, D. Ye. Volkov, D. A. Lopin, N. I. Yabluchanskiy. // Ukraí̈ns'kiy terapevtichniy zhurnal. – 2015. – № 4. – s. 101–106.
Influence of systolic blood pressure on clinical outcomes in elderly heart failure patients treated with nebivolol: data from the SENIORS trial / [M. / Montero-Perez-Barquero, M. Flather, M. Roughton et al.]. // Eur J Heart Fail. – 2014. – № 16. – p. 1009–15.
Hőgye M. Chronic heart failure with impaired left ventricular function (systolic heart failure) / M. Hőgye, T. Forster. // Orv Hetil. – 2012. – № 153. – p. 2021–9.
Drugs and pacemakers for vasovagal, carotid sinus and situational syncope [Electronic resource] / [J. J. Romme, J. B. Reitsma, C. N. Black et al.] // Cochrane Database Syst Rev. – 2011. – Access to resource: http://doi.org/10.1002/14651858.CD004194.pub3.
Treatment with higher dosages of heart failure medication is associated with improved outcome following cardiac resynchronization therapy [Electronic resource] / [S. Schmidt, D. Hürlimann, C. T. Starck et al.] // Eur Heart J. – 2014. – Access to resource: http://doi.org/10.1093/eurheartj/eht514.
Development of Atrioventricular Block and Diagnostic Value of Stored Electrograms in Patients With Sick Sinus Syndrome and Implanted Pacemaker / [J. Hosoda, T. Ishikawa, S. Sumita et al.]. // Circ J. – 2015. – № 79. – p. 1263–8.
Hoppe U. C. Heart rate reduction as a therapeutic strategy: novel options / U. C. Hoppe. // Internist (Berl). – 2006. – № 47. – p. 1289–93.
Maltseva M. S. Importance of QTc interval duration in pacing parameters optimization and therapeutic management of the patients with permanent cardiac pacing / M. S. Maltseva, D. E. Volkov. // Journal of V. N. Karazin` KhNU. – 2014. – № 27. – p. 50–73.
Shanina I. V. Frequency of detached cardiac drugs prescribing in patients of different classes QRS complex duration on the permanent pacing background / I. V. Shanina, D. E. Volkov. // Journal of V. N. Karazin’ KhNU. – 2014. – № 27. – p. 33–7.
Beta-blocker utilization and outcomes in patients receiving cardiac resynchronization therapy / A. Voigt, A. Shalaby, E. Adelstein, S. Saba. // Clin Cardiol. – 2010. – № 33. – p. 1–5.
Dzizinskiy A. A. Dinamika pul'sovogo davleniya na fone lecheniya amlodipinom i karvedilolom u bol'nykh arterial'noy gipertoniyey / A. A. Dzizinskiy, K. V. Protasov, O. V. Fedorishina. // Lechashchiy vrach. – 2008. – № 6. – s. 108–10.
A controlled study on the effect of verapamil on atrial tachycaarrhythmias in patients with brady-tachy syndrome implanted with a DDDR pacemaker / [G. Boriani, E. Bertaglia, A. Carboni et al.]. // Int J. Cardiol. – 2005. – № 104. – p. 73–6.
Verapamil improves the pacing-induced vasodilatation in symptomatic patients with hypertrophic cardiomyopathy / [P. P. Dimitrow, M. Krzanowski, J. Grodecki et al.]. // Int J Cardiol. – 2002. – № 83. – p. 239–47.
Relation of dosing of the renin-angiotensin system inhibitors after cardiac resynchronization therapy to long-term prognosis / [L. Mantziari, K. Guha, Z. Khalique et al.]. // Am J Cardiol. – 2012. – № 109. – p. 1619–25.
Вісник Харківського національного університету імені В. Н. Каразіна, серія Медицина має такі умови авторського права:
1. Автори зберігають авторські права та надають журналу право на першу публікацію разом із роботою, яка одночасно ліцензується згідно з ліцензією Creative Commons Attribution License, яка дозволяє іншим ділитися роботою з визнанням авторства роботи та першої публікації в цьому журналі.
2. Автори можуть укладати окремі додаткові договірні угоди щодо неексклюзивного розповсюдження опублікованої журналом версії роботи з підтвердженням її початкової публікації в цьому журналі.
3. Авторам дозволяється та заохочується публікувати свої роботи в Інтернеті до та під час процесу подання, оскільки це може призвести до продуктивного обміну, а також до раннього та більшого цитування опублікованої роботи.
